It is noteworthy that ILC3-to-ILC1 skewing in response to the cytokine IL-12 with increased levels of IFN-γ has been recognized as a pathogenic event during inflammatory bowel disease (Bernink et al, 2015; Forkel & Mjösberg, 2016). The gene discussed is IFNG; the disease is inflammatory bowel disease.